Press release – Transgene

Transgene Receives $22.2 million from the Sale of Part of its Minority Stake in Tasly BioPharmaceuticals

20200804 Transgene - Partial sale Tasly Shares EN

By nh|2020-08-04T16:32:49+02:00August 4th, 2020|Press release|Comments Off

CP TG4001+avelumab EN - Vdef-

By nh|2020-07-22T16:30:04+02:00July 22nd, 2020|Press release, TG4001, TG4001|Comments Off

20200709 PR Hypertrust Transgene EN

By nh|2020-07-08T18:29:33+02:00July 9th, 2020|Myvac, Press release, TG4050|Comments Off

20200622b - BT-001_AACR poster EN

By nh|2020-06-22T18:28:25+02:00June 22nd, 2020|BT-001, Invir.IO, Press release|Comments Off

20200622a - Transgene PR AACR 3 posters

By alcyon|2020-06-22T18:25:32+02:00June 22nd, 2020|BT-001, Invir.IO, Myvac, Press release|Comments Off

20200527 TG AGM 2020

By nh|2020-05-27T15:55:55+02:00May 27th, 2020|Press release|Comments Off

20200515 BT-001_AACR curtain raiser EN

By nh|2020-05-14T17:41:23+02:00May 15th, 2020|BT-001, Invir.IO, Press release|Comments Off

20200515_AACR myvac curtain raiser EN

By nh|2020-05-14T17:13:26+02:00May 15th, 2020|Myvac, Press release, TG4050|Comments Off

20200506 TG FINANCIAL T1- US

By nh|2020-05-06T16:30:35+02:00May 6th, 2020|Press release|Comments Off

20200504 - TG Vaxxell EN

By Lucie Larguier|2020-04-30T16:44:28+02:00May 4th, 2020|Press release|Comments Off